Edition:
United States

Peregrine Pharmaceuticals Inc (PPHM.OQ)

PPHM.OQ on NASDAQ Stock Exchange Capital Market

0.57USD
26 May 2017
Change (% chg)

$0.00 (+0.07%)
Prev Close
$0.57
Open
$0.57
Day's High
$0.57
Day's Low
$0.56
Volume
43,060
Avg. Vol
519,636
52-wk High
$0.77
52-wk Low
$0.28

PPHM.OQ

Chart for PPHM.OQ

About

Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company. The Company operates through two segments: Peregrine, which is engaged in the research and development of monoclonal antibodies for the treatment of cancer, and Avid, which is engaged in providing contract manufacturing services for third party customers... (more)

Overall

Beta: 2.44
Market Cap(Mil.): $168.50
Shares Outstanding(Mil.): 297.71
Dividend: --
Yield (%): --

Financials

  PPHM.OQ Industry Sector
P/E (TTM): -- 14.27 17.41
EPS (TTM): -0.16 -- --
ROI: -68.06 -7.17 -5.42
ROE: -78.77 -6.63 -4.68

BRIEF-Ronin Capital LLC reports 5.8 pct stake in Peregrine Pharmaceuticals

* Ronin Capital LLC reports 5.8 percent stake in Peregrine Pharmaceuticals Inc as of April 6 - sec filing Source text : http://bit.ly/2prmM8N Further company coverage:

Apr 17 2017

BRIEF-Peregrine Pharma presents data for Bavituximab's anti-tumor enhancing activity

* Peregrine Pharmaceuticals highlights clinical data presentation at aacr 2017 annual meeting supporting potential of Bavituximab to enhance anti-tumor activity of immunotherapy

Apr 04 2017

BRIEF-Peregrine Pharmaceuticals Q3 loss per share $0.04

* Sees FY 2017 revenue from avid bioservices business of $60 million-$65 million

Mar 13 2017

BRIEF-Ronin Capital reports 6.8 pct stake in Peregrine pharma as of feb 21 - SEC filing

* As of feb 21 Ronin Capital Llc Reports 6.8 Pct Stake In Peregrine Pharmaceuticals Inc- SEC filing Source text for Eikon: [ID:http://bit.ly/2lyZfNi] Further company coverage:

Mar 02 2017

More From Around the Web

Competitors

  Price Chg
DAIICHI SANKYO COMPANY, LIMITED (4568.T) ¥2,434 -3.50
HANALL BIOPHARMA (009420.KS) ₩13,150.00 -50.00
Pfizer Inc. (PFE.N) $32.14 -0.02
Johnson & Johnson (JNJ.N) $126.92 -0.61
Novartis AG (NOVN.S) CHF78.60 -0.50
Merck & Co., Inc. (MRK.N) $64.92 -0.12
Roche Holding Ltd. (ROG.S) CHF266.60 -0.60
Roche Holding Ltd. (RO.S) CHF267.75 +0.25
Bayer AG (BAYGn.DE) €116.70 -0.05
Bayer AG (BAYE.F) -- --

Earnings vs. Estimates